Risk factor
Strong trading liquidity
Profitability factor
Very low or no dividends
About
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, trading at n
Target Price
The average target price of LIVN is 74 and suggests 33% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell